Bioinformatics Solutions Inc. (BSI) researchers are pleased to announce their latest research “Deep learning enables de novo peptide sequencing from data-independent-acquisition mass spectrometry”, published this month in Nature Methods.
Personalized immunotherapy is revolutionizing cancer treatment. LC-MS/MS with data-independent acquisition (DIA) as an unbiased approach has been a major force to advance the development personalized neoantigen vaccines. This research presents a de novo peptide-sequencing method for DIA data analysis using deep learning.
Figure: The workflow of DeepNovo-DIA for de novo sequencing of DIA data.
The full article can be found here: Tran, N.H., et al. Deep learning enables de novo peptide sequencing from data-independent-acquisition mass spectrometry. Nature Methods. 20/12/2018.